(Q40442987)

20 September 2017

1 reference

title

Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis (English)

1 reference

20 September 2017

Effects of Nonsteroidal Antiinflammatory Drugs on Platelet Function and Systemic Hemostasis (English)

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

13 June 2024

author name string

A. I. Schafer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7608308

13 June 2024

language of work or name

1 reference

1 March 1995

1 reference

full work available at URL

20 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fj.1552-4604.1995.tb04050.x

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

https://accp1.onlinelibrary.wiley.com/doi/pdf/10.1002/j.1552-4604.1995.tb04050.x

13 June 2024

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

The Journal of Clinical Pharmacology

13 June 2024

published in

1 reference

20 September 2017

volume

35

1 reference

20 September 2017

issue

3

1 reference

20 September 2017

page(s)

209-219

1 reference

Trends in the utilization of non-steroidal anti-inflammatory drugs in the United States, 1986-1990

20 September 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Can gastroduodenal ulcers in NSAID users be prevented?

13 June 2024

4

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

NSAID adverse effects & interactions: who is at risk?

13 June 2024

5

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Regulatory functions of the vascular endothelium

13 June 2024

6

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Seminars in medicine of the Beth Israel Hospital, Boston. Platelet-endothelium interactions.

13 June 2024

7

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

von Willebrand factor binding to platelet GpIb initiates signals for platelet activation

13 June 2024

8

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Clinical implications of prostaglandin and thromboxane A2 formation (1).

13 June 2024

9

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation

13 June 2024

10

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells

13 June 2024

11

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells

13 June 2024

12

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Platelet interaction with vascular smooth muscle in synthesis of prostacyclin

13 June 2024

13

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Endogenous prostacyclin biosynthesis and platelet function during selective inhibition of thromboxane synthase in man.

13 June 2024

14

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase

13 June 2024

15

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man

13 June 2024

16

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

13 June 2024

17

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Aspirin selectively inhibits prostaglandin production in human platelets

13 June 2024

18

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Acetylation of prostaglandin synthase by aspirin

13 June 2024

19

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein

13 June 2024

20

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Inhibition of platelet prostaglandin synthetase by oral aspirin

13 June 2024

21

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence

13 June 2024

22

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Recovery of Endothelial Cell Prostacyclin Production after Inhibition by Low Doses of Aspirin

13 June 2024

24

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Sensitivity of fatty acid cyclooxygenase from human aorta to acetylation by aspirin

13 June 2024

25

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Characterization of prostacyclin synthesis in cultured human arterial smooth muscle cells, venous endothelial cells and skin fibroblasts

13 June 2024

26

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects

13 June 2024

27

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

A regimen for low-dose aspirin?

13 June 2024

28

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Suppression of eicosanoid biosynthesis during coronary angioplasty by fish oil and aspirin

13 June 2024

30

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Differential Inhibition by Aspirin of Vascular and Platelet Prostaglandin Synthesis in Atherosclerotic Patients

13 June 2024

31

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man

13 June 2024

32

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Differential effect of aspirin on thromboxane and prostaglandin biosynthesis in man.

13 June 2024

33

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

13 June 2024

34

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Effect of alternate-day regular and enteric-coated aspirin on platelet aggregation, bleeding time, and thromboxane A2 levels in bleeding-time blood

13 June 2024

35

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Cumulative antiplatelet effect of low-dose enteric coated aspirin

13 June 2024

36

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin

13 June 2024

37

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

The effect of ibuprofen on platelet function in vivo

13 June 2024

38

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Lack of covalent modification of prostaglandin synthetase (cyclo-oxygenase) by indomethacin

13 June 2024

39

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin

13 June 2024

40

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

THE AGGREGATION OF BLOOD PLATELETS

13 June 2024

41

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

The bleeding time as a screening test for evaluation of platelet function

13 June 2024

42

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Development and evaluation of a disposable device for performing simultaneous duplicate bleeding time determinations

13 June 2024

47

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Bleeding time: a guide to its diagnostic and clinical utility

13 June 2024

50

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

A critical reappraisal of the bleeding time

13 June 2024

51

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

A comparison of template bleeding time with mucosal petechiometry as a measure of the platelet function defect induced by aspirin

13 June 2024

53

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Does aspirin prolong bleeding from gastric biopsies in man?

13 June 2024

54

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

The effect of salicylates on the hemostatic properties of platelets in man

13 June 2024

55

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Formation of Prostaglandins during the Aggregation of Human Blood Platelets

13 June 2024

56

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Impaired platelet-connective-tissue reaction in man after aspirin ingestion

13 June 2024

57

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Effects of salicylates on human platelets.

13 June 2024

58

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Clinical pharmacology of platelet cyclooxygenase inhibition

13 June 2024

59

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Aspirin: A paradoxical effect on bleeding-time

13 June 2024

61

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Aspirin and bleeding-time

13 June 2024

62

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Aspirin and bleeding-time

13 June 2024

63

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Effect on platelet aggregation of oral administration of 10 non-steroidal analgesics to humans

13 June 2024

66

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Effects of diflunisal on platelet function and fecal blood loss

13 June 2024

67

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Relation between plasma concentration of indomethacin and its effect on prostaglandin synthesis and platelet aggregation in man

13 June 2024

68

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

The effect of a new non-steroidal anti-inflammatory agent, sulindac, on platelet function

13 June 2024

69

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Effect of anti-inflammatory agents on platelets

13 June 2024

70

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Tolerance and pharmacology of ibuprofen

13 June 2024

71

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Effect of ibuprofen on platelet function in normal subjects and hemophiliac patients

13 June 2024

72

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Comparative effect of ibuprofen on endothelial and platelet prostaglandin synthesis

13 June 2024

73

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Kinetics of ibuprofen effect on platelet and endothelial prostanoid release

13 June 2024

74

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Relationships between thromboxane production, platelet aggregability, and serum concentrations of ibuprofen or flurbiprofen

13 June 2024

75

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Effect of racemic ibuprofen dose on the magnitude and duration of platelet cyclo-oxygenase inhibition: relationship between inhibition of thromboxane production and the plasma unbound concentration of S(+)-ibuprofen.

13 June 2024

76

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

The stereoselective uptake of ibuprofen enantiomers into adipose tissue

13 June 2024

77

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Interaction of ibuprofen and warfarin on primary haemostasis

13 June 2024

79

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Bleeding tendency, platelet function, and pharmacokinetics of ibuprofen and zidovudine in HIV(+) hemophilic men.

13 June 2024

80

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

The effect of continuous intravenous indomethacin infusion on bleeding time and postoperative pain in patients undergoing emergency surgery of the lower extremities

13 June 2024

81

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Effects of ketorolac tromethamine on hemostasis in volunteers

13 June 2024

82

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Comparison of i.m. ketorolac trometamol and morphine sulphate for pain relief after cholecystectomy

13 June 2024

84

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study

13 June 2024

85

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Aspirin as a risk factor for hemorrhage in patients with head injuries

13 June 2024

88

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin

13 June 2024

90

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Adverse effects of low-dose aspirin in a healthy elderly population

13 June 2024

92

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Aspirin-induced prolongation of bleeding time and perioperative blood loss.

13 June 2024

94

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Use of desmopressin to prevent bleeding complications in patients treated with aspirin.

13 June 2024

95

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Aspirin usage and perioperative blood loss in patients undergoing unexpected operations

13 June 2024

96

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Aspirin- and Coumadin®-Related Bleeding After Coronary-Artery Bypass Graft Surgery

13 June 2024

98

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting

13 June 2024

99

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study

13 June 2024

100

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Preoperative aspirin therapy and reoperation for bleeding after coronary artery bypass surgery

13 June 2024

101

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. Department of Veterans Affairs Cooperative Study on Antiplatelet Therapy

13 June 2024

102

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Effect of preoperative antiplatelet drugs on vascular prostacyclin synthesis

13 June 2024

103

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Determinants of homologous blood usage utilizing autologous platelet-rich plasma in cardiac operations

13 June 2024

104

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

A prospective study of aspirin's effect on red blood cell loss in cardiac surgery

13 June 2024

105

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Neonatal intracranial hemorrhage and maternal use of aspirin

13 June 2024

107

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Effects of acetylsalicylic-acid ingestion on maternal and neonatal hemostasis.

13 June 2024

108

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Potential Renal, Haematological and Allergic Adverse Effects Associated with Nonsteroidal Anti-Inflammatory Drugs

13 June 2024

109

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Effects of fenoprofen and aspirin on gastrointestinal microbleeding in man

13 June 2024

110

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

An endoscopic evaluation of the effects of non-steroidal anti-inflammatory drugs on the gastric mucosa

13 June 2024

111

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Gastrointestinal blood loss. Effect of aspirin, fenoprofen, and acetaminophen in rheumatoid arthritis as determined by sequential gastroscopy and radioactive fecal markers

13 June 2024

112

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Comparison of gastrointestinal effects of aspirin and fenoprofen. A double blind crossover study

13 June 2024

113

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

The effects of ibuprofen, indomethacin, aspirin, naproxen, and placebo on the gastric mucosa of normal volunteers: a gastroscopic and photographic study

13 June 2024

114

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents

13 June 2024

117

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer

13 June 2024

118

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Clinical differences among nonsteroidal antiinflammatory drugs: implications for therapeutic substitution in ambulatory patients.

13 June 2024

119

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Double-blind controlled trial of indomethacin as an adjunct to narcotic analgesia after major abdominal surgery

13 June 2024

120

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Indomethacin as an analgesic after hysterectomy.

13 June 2024

121

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

The effect of continuous intravenous indomethacin infusion on bleeding time and postoperative pain in patients undergoing emergency surgery of the lower extremities

13 June 2024

122

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Diclofenac for pain after hip surgery

13 June 2024

123

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Ethanol potentiation of aspirin-induced prolongation of the bleeding time

13 June 2024

126

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Confirmation that ethanol potentiates aspirin-induced prolongation of the bleeding time

13 June 2024

127

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Spontaneous hyphema associated with ingestion of aspirin and ethanol

13 June 2024

128

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Effects of aspirin and alcohol on platelet thromboxane synthesis and vascular prostacyclin synthesis

13 June 2024

129

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Interaction of ethanol, prostacyclin, and aspirin in determining human platelet reactivity in vitro

13 June 2024

130

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

The Post-Aspirin Bleeding Time: a Screening Test for Evaluating Haemostatic Disorders

13 June 2024

132

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Haematological effects of non-narcotic analgesics.

13 June 2024

133

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Drug interaction with coumarin derivative anticoagulants. Standing Advisory Committee for Haematology of the Royal College of Pathologists

13 June 2024

134

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Interaction between Oral Anti-Coagulant Drugs and Non-Steroidal Anti-Inflammatory Agents: A Review

13 June 2024

135

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Clinical Pharmacokinetics of Non-steroidal Anti-inflammatory Drugs

13 June 2024

136

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Nonsteroidal antiinflammatory drugs--differences and similarities

13 June 2024

137

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Prothrombin time ratio and other factors associated with bleeding in patients treated with warfarin

13 June 2024

138

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease

13 June 2024

139

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Increased frequency of haemarthroses in haemophilic patient treated with zidovudine

13 June 2024

140

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

Paracetamol and phenacetin.

13 June 2024

141

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1995.TB04050.X

13 June 2024

Identifiers

1 reference

20 September 2017

1 reference